TLSI
TriSalus Life Sciences, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$3.89
+11.78%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 29.84x
- P/S forward
- 3.28x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 36.57x
- Price / sales
- 5.31x
- Price / cash flow
- -8.18x
Enterprise value
- Enterprise value
- $227.7M
- EV / sales
- 5.05x
- EV / EBITDA
- -10.51x
- EV / EBIT
- -7.46x
- Market cap
- $239.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026